New England Research Associates, LLC /ID# 154004

Bridgeport, Connecticut 06606-1827

0 studies enrolling now · 1 studies all time

What they study most

Psoriasis

Studies at this site

• A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) — Completed